Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d'Etudes des Lymphomes de l'Adulte
published in: Blood
date of publication: 2010-06-14
language: English
main subject: patient, chemotherapy
Cites articles 13
Date
Title
Article - wd:Q34184706